반응식
[N+:1]([C:4]1[CH:9]=[CH:8][C:7]([C:10]2[C:14]([C:15]#[N:16])=[C:13]([N:17]=[CH:18][N:19]([CH3:21])[CH3:20])[NH:12][N:11]=2)=[CH:6][CH:5]=1)([O-])=O>C1COCC1.[Pd]>[NH2:1][C:4]1[CH:9]=[CH:8][C:7]([C:10]2[C:14]([C:15]#[N:16])=[C:13]([N:17]=[CH:18][N:19]([CH3:21])[CH3:20])[NH:12][N:11]=2)=[CH:6][CH:5]=1참가 물질
4
실험 절차
In the presence of 30 mg of Pd/C (5%), 142 mg (0.50 mmol) of N'-[3-(4-nitro-phenyl)-4-cyano-1H-pyrazol-5-yl]-N,N-dimethylformamidine are hydrogenated in 20 ml of THF. Filtering, concentration by evaporation and crystallization from ethyl acetate/diethyl ether/hexane yield N'-[3-(4-amino-phenyl)-4-cyano-1H-pyrazol-5-yl]-N,N-dimethylformamidine; TLC: Rf =0.07 (ethyl acetate:hexane=3:1); FAB-MS: (M+H)+ =255.
후처리
- filtrationFiltering
- concentrationconcentration
- customby evaporation and crystallization from ethyl acetate/diethyl ether/hexane
출처 및 근거
- ORD 기록
- ord-aaa5dd31487e4c4e8c558a0038724872
- 출처 데이터셋
- uspto-grants-1999_11
- 특허 번호
- US05981533
연결된 노트
불러오는 중…